ES2551053B1 - Polyvitamin food supplement for pregnant women - Google Patents
Polyvitamin food supplement for pregnant women Download PDFInfo
- Publication number
- ES2551053B1 ES2551053B1 ES201531147A ES201531147A ES2551053B1 ES 2551053 B1 ES2551053 B1 ES 2551053B1 ES 201531147 A ES201531147 A ES 201531147A ES 201531147 A ES201531147 A ES 201531147A ES 2551053 B1 ES2551053 B1 ES 2551053B1
- Authority
- ES
- Spain
- Prior art keywords
- vitamin
- pregnant women
- food supplement
- magnesium
- polyvitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000015872 dietary supplement Nutrition 0.000 title claims abstract description 19
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 20
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 19
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 17
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 15
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims abstract description 13
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 235000019152 folic acid Nutrition 0.000 claims abstract description 11
- 239000011724 folic acid Substances 0.000 claims abstract description 11
- 239000000203 mixture Substances 0.000 claims abstract description 11
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229960000304 folic acid Drugs 0.000 claims abstract description 10
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 9
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000011709 vitamin E Substances 0.000 claims abstract description 9
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 9
- 229940046009 vitamin E Drugs 0.000 claims abstract description 9
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 8
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims abstract description 8
- 229910052742 iron Inorganic materials 0.000 claims abstract description 8
- 235000001055 magnesium Nutrition 0.000 claims abstract description 8
- 239000011777 magnesium Substances 0.000 claims abstract description 8
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 8
- 239000011718 vitamin C Substances 0.000 claims abstract description 8
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 8
- 241000186604 Lactobacillus reuteri Species 0.000 claims abstract description 7
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims abstract description 7
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229960002685 biotin Drugs 0.000 claims abstract description 7
- 235000020958 biotin Nutrition 0.000 claims abstract description 7
- 239000011616 biotin Substances 0.000 claims abstract description 7
- 235000013675 iodine Nutrition 0.000 claims abstract description 7
- 239000011630 iodine Substances 0.000 claims abstract description 7
- 229960002358 iodine Drugs 0.000 claims abstract description 7
- 229910052740 iodine Inorganic materials 0.000 claims abstract description 7
- 239000006041 probiotic Substances 0.000 claims abstract description 7
- 235000018291 probiotics Nutrition 0.000 claims abstract description 7
- 235000016804 zinc Nutrition 0.000 claims abstract description 7
- 239000011701 zinc Substances 0.000 claims abstract description 7
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 7
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 claims abstract description 6
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims abstract description 6
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229940001882 lactobacillus reuteri Drugs 0.000 claims abstract description 6
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 claims abstract description 5
- 235000010374 vitamin B1 Nutrition 0.000 claims abstract description 5
- 239000011691 vitamin B1 Substances 0.000 claims abstract description 5
- 235000019163 vitamin B12 Nutrition 0.000 claims abstract description 5
- 239000011715 vitamin B12 Substances 0.000 claims abstract description 5
- 235000019158 vitamin B6 Nutrition 0.000 claims abstract description 5
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 5
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 4
- 230000000529 probiotic effect Effects 0.000 claims abstract description 4
- 235000019164 vitamin B2 Nutrition 0.000 claims abstract description 4
- 239000011716 vitamin B2 Substances 0.000 claims abstract description 4
- 235000019160 vitamin B3 Nutrition 0.000 claims abstract description 4
- 239000011708 vitamin B3 Substances 0.000 claims abstract description 4
- 239000011675 vitamin B5 Substances 0.000 claims abstract description 4
- 235000009492 vitamin B5 Nutrition 0.000 claims abstract description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 7
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 5
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 4
- 229960003512 nicotinic acid Drugs 0.000 claims description 4
- 229960002477 riboflavin Drugs 0.000 claims description 4
- 229940011671 vitamin b6 Drugs 0.000 claims description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 3
- 229930003779 Vitamin B12 Natural products 0.000 claims description 3
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 3
- 229960003495 thiamine Drugs 0.000 claims description 3
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 2
- 229930003451 Vitamin B1 Natural products 0.000 claims description 2
- 229930003471 Vitamin B2 Natural products 0.000 claims description 2
- 229930003537 Vitamin B3 Natural products 0.000 claims description 2
- 229930003571 Vitamin B5 Natural products 0.000 claims description 2
- 229960002079 calcium pantothenate Drugs 0.000 claims description 2
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims 1
- 230000035935 pregnancy Effects 0.000 description 17
- 210000003754 fetus Anatomy 0.000 description 10
- 239000002775 capsule Substances 0.000 description 8
- 230000018109 developmental process Effects 0.000 description 7
- 239000013589 supplement Substances 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 150000003722 vitamin derivatives Chemical class 0.000 description 5
- 206010010356 Congenital anomaly Diseases 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 4
- 208000007502 anemia Diseases 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 210000000653 nervous system Anatomy 0.000 description 4
- 208000032170 Congenital Abnormalities Diseases 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 230000007170 pathology Effects 0.000 description 3
- 235000019156 vitamin B Nutrition 0.000 description 3
- 239000011720 vitamin B Substances 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 208000005107 Premature Birth Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000007698 birth defect Effects 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940090949 docosahexaenoic acid Drugs 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 2
- 229940012843 omega-3 fatty acid Drugs 0.000 description 2
- 239000006014 omega-3 oil Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 201000011461 pre-eclampsia Diseases 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 208000019206 urinary tract infection Diseases 0.000 description 2
- 208000010484 vulvovaginitis Diseases 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 1
- 206010002942 Apathy Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010004906 Biotin deficiency Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 208000004547 Hallucinations Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 208000008167 Magnesium Deficiency Diseases 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000736262 Microbiota Species 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 102000006386 Myelin Proteins Human genes 0.000 description 1
- 108010083674 Myelin Proteins Proteins 0.000 description 1
- 208000031845 Pernicious anaemia Diseases 0.000 description 1
- 206010040925 Skin striae Diseases 0.000 description 1
- 208000031439 Striae Distensae Diseases 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 208000002296 eclampsia Diseases 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 230000008175 fetal development Effects 0.000 description 1
- 229940014144 folate Drugs 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 208000037824 growth disorder Diseases 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 208000018773 low birth weight Diseases 0.000 description 1
- 231100000533 low birth weight Toxicity 0.000 description 1
- 230000003050 macronutrient Effects 0.000 description 1
- 235000021073 macronutrients Nutrition 0.000 description 1
- 235000004764 magnesium deficiency Nutrition 0.000 description 1
- 229940091250 magnesium supplement Drugs 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000036630 mental development Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 210000005012 myelin Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 210000000276 neural tube Anatomy 0.000 description 1
- 230000007472 neurodevelopment Effects 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000000324 neuroprotective effect Effects 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Complemento alimenticio polivitamínico para mujeres embarazadas que comprende una asociación de ácido docosahexaenoico (DHA), Magnesio, Vitamina C, hierro, vitaminas B1, B2, B3, B5, B6 y B12, vitamina E, ácido fólico, biotina, yodo y zinc, y una mezcla de agentes probióticos constituida por Lactobacillus Rhamnosus y Lactobacillus Reuteri.Polyvitamin food supplement for pregnant women comprising an association of docosahexaenoic acid (DHA), Magnesium, Vitamin C, iron, vitamins B1, B2, B3, B5, B6 and B12, vitamin E, folic acid, biotin, iodine and zinc, and a mixture of probiotic agents consisting of Lactobacillus Rhamnosus and Lactobacillus Reuteri.
Description
55
1010
15fifteen
20twenty
2525
DESCRIPCIONDESCRIPTION
Complemento alimenticio polivitammico para mujeres embarazadas Campo de la invencionMultivitamin food supplement for pregnant women Field of the invention
La presente invencion se refiere al uso de probioticos en la composition de complementos alimenticios polivitammicos para mujeres embarazadas.The present invention relates to the use of probiotics in the composition of polyvinyl food supplements for pregnant women.
Antecedentes de la invencionBackground of the invention
Los Complementos Alimenticios son productos cuyo fin es complementar una dieta normal y consisten en fuentes concentradas de nutrientes o de otras sustancias que tienen un efecto nutricional o fisiologico en forma simple o combinada. Son comercializados en forma dosificada, es decir capsulas, pastillas, tabletas, pfldoras que deben tomarse en pequenas cantidades unitarias.Food Supplements are products whose purpose is to complement a normal diet and consist of concentrated sources of nutrients or other substances that have a nutritional or physiological effect in a simple or combined form. They are marketed in a dosage form, that is capsules, pills, tablets, pills that must be taken in small unit quantities.
Estos complementos o suplementos alimenticios no son considerados medicamentos ya que no curan enfermedades, sino que mejoran el bienestar de la persona, por lo que estan destinados a individuos con buena salud y no necesitan prescription medica.These supplements or nutritional supplements are not considered medications since they do not cure diseases, but improve the well-being of the person, so they are intended for individuals in good health and do not need a prescription.
Se conocen complementos polivitammicos para a mujeres embarazadas cuya finalidad es mejorar las condiciones del embarazo de la madre y ayudar al desarrollo del feto.Polivitammicos supplements are known for pregnant women whose purpose is to improve the conditions of the mother's pregnancy and help the development of the fetus.
La patente WO2003017945, describe un suplemento para mujeres embarazadas, que contienen DHA, varias vitaminas y minerales. Se reivindica que tomando estos suplementos se podria beneficiar la salud tanto de la madre como del bebe.WO2003017945, discloses a supplement for pregnant women, containing DHA, various vitamins and minerals. It is claimed that taking these supplements could benefit the health of both the mother and the baby.
Los componentes principales descritos en el estado de la tecnica para este tipo de complemento alimenticio son: Acidos grasos omega 3, Magnesio, Vitamina C, hierro, vitaminas del grupo B, vitamina E, acido folico, biotina, yodo y zinc.The main components described in the state of the art for this type of food supplement are: Omega 3 fatty acids, Magnesium, Vitamin C, iron, B vitamins, vitamin E, folic acid, biotin, iodine and zinc.
Los acidos grasos omega 3 son acidos grasos esenciales poliinsaturados, que se encuentran en alta proportion en los tejidos de ciertos pescados, y en algunas fuentes vegetales. El ser humano no puede generar acidos a partir de otros componentes, por lo que los acidos omega 3 deben ingerirse con la dieta. Los acidos omega-3 tienen diversos efectos entre ellos se destaca, el aumentar el tiempo de coagulation de la sangre, efectos beneficos sobre el cerebro, y durante el embarazo tienen influencia en el desarrollo del feto.Omega 3 fatty acids are polyunsaturated essential fatty acids, which are found in high proportion in the tissues of certain fish, and in some plant sources. The human being cannot generate acids from other components, so omega 3 acids must be ingested with the diet. Omega-3 acids have various effects among them, the increase in blood clotting time, beneficial effects on the brain, and during pregnancy have an influence on the development of the fetus.
Existen seis tipos diferentes de acido omega 3, el acido docosahexaenoico (DHA) es uno de ellos.There are six different types of omega 3 acid, docosahexaenoic acid (DHA) is one of them.
55
1010
15fifteen
20twenty
2525
El DHA tiene un efecto positivo sobre la estructura y funcion de las membranas celulares y es un precursor de metabolitos anti-inflamatorios y neuroprotectores. Se usa como complemento alimenticio en diversos preparados habiendose probado que mejora el desarrollo del feto.DHA has a positive effect on the structure and function of cell membranes and is a precursor of anti-inflammatory and neuroprotective metabolites. It is used as a food supplement in various preparations having been proven to improve the development of the fetus.
El magnesio es un mineral que cumple un rol fundamental durante el embarazo ya que interviene en la generation y reparation de tejidos. Ademas tiene una action reequilibrante sobre el sistema circulatorio, protege contra los infartos y estimula la contractilidad cardiaca.Magnesium is a mineral that plays a fundamental role during pregnancy as it is involved in the generation and repair of tissues. It also has a rebalancing action on the circulatory system, protects against heart attacks and stimulates cardiac contractility.
Las deficiencias de magnesio se asocian a mayor riesgo de preeclampsia, eclampsia, mortalidad infantil y malformaciones congenitas. Varias investigaciones coinciden en que manteniendo unos niveles adecuados de magnesio durante el embarazo, se reducen las contracciones uterinas antes de la semana 35 del embarazo.Magnesium deficiencies are associated with an increased risk of preeclampsia, eclampsia, infant mortality and congenital malformations. Several investigations agree that maintaining adequate levels of magnesium during pregnancy reduces uterine contractions before the 35th week of pregnancy.
La vitamina C es uno de los nutrientes esenciales para mujeres embarazadas ya que proporciona protection antioxidante contra la enfermedad y protection contra los defectos de nacimiento. Aumenta la inmunidad, una ventaja especialmente util para las mujeres embarazadas que limitan su medication por temor a poner en peligro a los bebes. El acido ascorbico tambien protege de la anemia, ya ayuda al cuerpo a absorber el hierro. Tambien de interes para las mujeres preocupadas por las estrias es la capacidad del acido ascorbico para construir el colageno.Vitamin C is one of the essential nutrients for pregnant women as it provides antioxidant protection against disease and protection against birth defects. Increases immunity, an especially useful advantage for pregnant women who limit their medication for fear of endangering babies. Ascorbic acid also protects against anemia, it already helps the body absorb iron. Also of interest to women concerned with stretch marks is the ability of ascorbic acid to build collagen.
El hierro reduce la probabilidad de riesgo de anemia, interviniendo en la formation de hemoglobina y globulos rojos.Iron reduces the likelihood of anemia risk, intervening in the formation of hemoglobin and red blood cells.
Las vitaminas del grupo B durante el embarazo influyen en el desarrollo del sistema nervioso y la formacion de los globulos rojos del feto.B vitamins during pregnancy influence the development of the nervous system and the formation of the red blood cells of the fetus.
• B1 tiamina: Es una vitamina hidrosoluble, actua como coenzima y tiene un papel esencial en el sistema nervioso y el metabolismo de macro-nutrientes. Su ingesta se ha relacionado con el control de los calambres durante el embarazo.• B1 thiamine: It is a water-soluble vitamin, acts as coenzyme and has an essential role in the nervous system and macro-nutrient metabolism. Its intake has been related to the control of cramps during pregnancy.
• B2 riboflavina: Vitamina hidrosoluble que participa en varios procesos metabolicos vitales del organismo, para un funcionamiento celular normal, crecimiento y production de energia. La riboflavina puede prevenir en el feto bajo peso al nacer, asi como defectos congenitos y muerte.• B2 riboflavin: Water-soluble vitamin that participates in several vital metabolic processes of the organism, for normal cellular functioning, growth and energy production. Riboflavin can prevent low birth weight in the fetus, as well as birth defects and death.
55
1010
15fifteen
20twenty
2525
3030
• B3 niacina: Esta vitamina estimula el apetito e interviene en la absorcion de los alimentos en el tubo digestivo. Tambien ayuda a contrarrestar la hiperlipemia, as^ como hipoglucemia. Durante el embarazo aumenta el requerimiento de niacina• B3 niacin: This vitamin stimulates appetite and is involved in the absorption of food in the digestive tract. It also helps counteract hyperlipidemia, as well as hypoglycemia. During pregnancy the niacin requirement increases
• B6 piridoxina: Esta vitamina es importante para el metabolismo de aminoacidos y carbohidratos. Tiene un papel fundamental en el desarrollo del sistema nervioso central y en la formacion de compuestos relacionados con la hemoglobina, por lo que su ingesta durante el embarazo y la lactancia previene anormalidades neurologicas y del comportamiento en el recien nacido. Tambien se ha observado que los suplementos con vitamina B6 reducen las nauseas y los vomitos durante el embarazo.• B6 pyridoxine: This vitamin is important for the metabolism of amino acids and carbohydrates. It has a fundamental role in the development of the central nervous system and in the formation of hemoglobin-related compounds, so its intake during pregnancy and lactation prevents neurological and behavioral abnormalities in the newborn. It has also been observed that supplements with vitamin B6 reduce nausea and vomiting during pregnancy.
• B12 cianocobalamina: Esencial para el mantenimiento de las celulas nerviosas y de los globulos rojos. Un aporte adecuado de vitamina B12 evita el desarrollo de anemia perniciosa en el bebe. Tambien interviene en el proceso de almacenamiento del acido folico, por lo que contribuye en la prevencion de malformaciones fetales. Tambien previene defectos del tubo neural, retraso en el proceso de obtencion de mielina de las fibras nerviosas, del sistema nervioso del feto; abortos espontaneos y preeclampsia.• B12 cyanocobalamin: Essential for the maintenance of nerve cells and red blood cells. An adequate supply of vitamin B12 prevents the development of pernicious anemia in the baby. It also intervenes in the process of storage of folic acid, so it contributes to the prevention of fetal malformations. It also prevents defects of the neural tube, delay in the process of obtaining myelin from the nerve fibers, from the nervous system of the fetus; spontaneous abortions and preeclampsia.
La vitamina E, es un nutriente clave en embarazadas, pues tiene un impacto positivo en el sistema nervioso, contribuye a impulsar el desarrollo neurologico del bebe y le fortalece contra las infecciones. Niveles inadecuados de vitamina E estan asociados con un aumento de las infecciones, con anemia, asma y retraso del crecimiento del feto. Tambien, varias investigaciones confirman que la ingesta de una combination de vitamina E y C por dia disminuye el riesgo de desarrollar hipertension arterial en mujeres con alto riesgo cuando comenzaron la ingesta durante las semanas 16-22 del embarazo.Vitamin E is a key nutrient in pregnant women, as it has a positive impact on the nervous system, helps boost the baby's neurological development and strengthens it against infections. Inadequate levels of vitamin E are associated with an increase in infections, with anemia, asthma and stunting of the fetus. Also, several investigations confirm that the ingestion of a combination of vitamin E and C per day decreases the risk of developing high blood pressure in women at high risk when they began intake during weeks 16-22 of pregnancy.
El acido folico es un tipo de vitamina del complejo B. Es la forma artificial del folato que se encuentra en suplementos y en los alimentos. Es hidrosoluble por lo que las cantidades sobrantes de la vitamina, se excretan por la orina no acumulandose en el organismo, por lo que debe recibirse un aporte continuo de acido folico. Contribuye al trabajo celular y en el crecimiento de los tejidos. La ingesta adecuada de acido folico antes y durante el embarazo ayuda a prevenir ciertas anomalias congenitas, o alteraciones como la anemia.Folic acid is a type of vitamin B complex. It is the artificial form of folate found in supplements and food. It is water soluble so that the remaining amounts of the vitamin are excreted in the urine not accumulating in the body, so you must receive a continuous supply of folic acid. It contributes to cell work and tissue growth. Adequate intake of folic acid before and during pregnancy helps prevent certain congenital anomalies, or alterations such as anemia.
La biotina en compuestos alimenticios se usa para prevenir y tratar la deficiencia de biotina asociada con el embarazo, por lo que se administra de forma preventiva durante el embarazo. El diagnostico de esta deficiencia es clmico, y sus principales manifestaciones son perdida de cabello (a menudo con perdida de color), y erupciones rojas y escamosas alrededor de losBiotin in food compounds is used to prevent and treat biotin deficiency associated with pregnancy, so it is administered preventively during pregnancy. The diagnosis of this deficiency is climactic, and its main manifestations are hair loss (often with loss of color), and red and scaly rashes around the
55
1010
15fifteen
20twenty
2525
ojos, nariz y boca. Otros smtomas incluyen depresion, apatia, alucinaciones y hormigueo en los brazos y piernaseyes, nose and mouth Other symptoms include depression, apathy, hallucinations and tingling in the arms and legs
El yodo es imprescindible para la smtesis de las hormonas tiroideas, claves para el desarrollo mental y el crecimiento del feto y neonato.Iodine is essential for the synthesis of thyroid hormones, keys for mental development and the growth of the fetus and neonate.
El zinc es un mineral que es fundamental para el correcto funcionamiento del sistema reproductivo y el desarrollo fetal, ya que ademas de ser responsable de la calidad del esperma y ovulos, contribuye en el rapido crecimiento del bebe durante el embarazo.Zinc is a mineral that is essential for the proper functioning of the reproductive system and fetal development, since in addition to being responsible for the quality of sperm and ovules, it contributes to the rapid growth of the baby during pregnancy.
Los componentes de estos complementos alimenticios tienen como finalidad el mejorar las condiciones del embarazo y ayudar al desarrollo del feto, sin embargo sin embargo hay algunas patologias como vulvovaginitis, vaginosis, partos prematuros e infecciones del tracto urinario que no pueden prevenirse con ellos.The components of these food supplements are intended to improve pregnancy conditions and help the development of the fetus, however there are some pathologies such as vulvovaginitis, vaginosis, premature births and urinary tract infections that cannot be prevented with them.
No se han descrito formulaciones de complementos alimenticios destinados a la mejora de la fertilidad femenina que incorporen combinaciones de agentes probioticos.Formulations of food supplements intended to improve female fertility that incorporate combinations of probiotic agents have not been described.
Descripcion de la invencionDescription of the invention
La invencion se refiere un complemento alimenticio polivitammico para mujeres embarazadas que incluye una combination de probioticos con la finalidad de preservar a la embarazada de algunas patologias comunes, modulando una respuesta inmune y reduciendo el riesgo de determinadas respuestas alergicas. Tambien actuan regulando la adherencia de protemas, aspecto fundamental en el papel de barrera de la mucosa epitelial, degradan toxinas y reducen la posibilidad de implantation y el efecto negativo que provocan otras bacterias oportunistas que invaden la mucosa vaginal.The invention relates to a multivitamin nutritional supplement for pregnant women that includes a combination of probiotics in order to preserve the pregnant woman from some common pathologies, modulating an immune response and reducing the risk of certain allergic responses. They also act by regulating the adhesion of proteins, a fundamental aspect in the barrier role of the epithelial mucosa, degrade toxins and reduce the possibility of implantation and the negative effect caused by other opportunistic bacteria that invade the vaginal mucosa.
El nuevo complemento alimenticio comprende una asociacion de:The new food supplement includes an association of:
a) Una mezcla constituida por acido docosahexaenoico (DHA), Magnesio, Vitamina C, hierro, vitaminas B1, B2, B3, B5, B6Y B12, vitamina E, acido folico, biotina, yodo y zinc.a) A mixture consisting of docosahexaenoic acid (DHA), Magnesium, Vitamin C, iron, vitamins B1, B2, B3, B5, B6Y B12, vitamin E, folic acid, biotin, iodine and zinc.
b) Una mezcla de agentes probioticos constituida por Lactobacillus Rhamnosus y Lactobacillus Reuteri.b) A mixture of probiotic agents consisting of Lactobacillus Rhamnosus and Lactobacillus Reuteri.
La primera mezcla tiene objeto la mejora las condiciones del embarazo y la ayuda al desarrollo del feto.The first mixture is aimed at improving pregnancy conditions and helping the fetus to develop.
55
1010
15fifteen
20twenty
2525
3030
Respecto a la segunda mezcla, los Lactobacillus Rhamnosus y Reuteri, estan presentes de forma natural en la microflora vaginal. La administration de ambas cepas en mujeres embarazadas ha demostrado una mejora de la microbiota, aspecto fundamental para prevenir algunas patologias como son la vulvovaginitis, vaginosis, partos prematuros, e infecciones del tracto urinario.Regarding the second mixture, Lactobacillus Rhamnosus and Reuteri, are naturally present in the vaginal microflora. The administration of both strains in pregnant women has shown an improvement in the microbiota, a fundamental aspect to prevent some pathologies such as vulvovaginitis, vaginosis, premature births, and urinary tract infections.
El complemento alimenticio esta formulado para administrarse por via oral, por lo tanto, puede presentarse en forma de capsula, comprimido, granulado, ventajosamente en forma de capsula. Si el complemento alimenticio se presenta en forma de capsula blanda o capsula, la envuelta de dichas capsulas blandas o dichas capsulas puede contener especialmente gelatina animal, como gelatina de pescado, glicerina o un material de origen vegetal, como un derivado de celulosa o de almidon, o una protema vegetal. Si el complemento alimenticio se presenta en forma de capsula, comprimido o granulado, la mezcla de activos puede fijarse en un soporte polvoriento, como sflice, celulosa y maltodextrina.The food supplement is formulated to be administered orally, therefore, it can be presented as a capsule, compressed, granulated, advantageously as a capsule. If the food supplement is in the form of a soft capsule or capsule, the shell of said soft capsules or said capsules may contain especially animal gelatin, such as fish jelly, glycerin or a material of plant origin, such as a cellulose or starch derivative , or a vegetable protein. If the food supplement is in the form of a capsule, tablet or granulate, the active mixture can be fixed on a dusty support, such as silica, cellulose and maltodextrin.
El complemento alimenticio de la invention responde preferiblemente a la siguiente composition ponderal:The food supplement of the invention preferably responds to the following weight composition:
Para una capsulaFor a capsule
- - -
- acido docosahexaenoico (DHA) 350-410 mg Docosahexaenoic acid (DHA) 350-410 mg
- - -
- Magnesio, 90-95 mg Magnesium, 90-95 mg
- - -
- Vitamina C 79-82 mg Vitamin C 79-82 mg
- - -
- Hierro, 27-29 mg Iron, 27-29 mg
- - -
- Vitamina B1 1-1,5 mg Vitamin B1 1-1.5 mg
- - -
- Vitamina B2 1-1,5 mg Vitamin B2 1-1.5 mg
- - -
- Vitamina B3 14-17 mg Vitamin B3 14-17 mg
- - -
- Vitamina B5 6-7 mg Vitamin B5 6-7 mg
- - -
- Vitamina B6 1-2 mg Vitamin B6 1-2 mg
- - -
- Vitamina B12 2-3 mg Vitamin B12 2-3 mg
- - -
- Vitamina E 16-19 mg Vitamin E 16-19 mg
- - -
- Acido Folico 0,3-0,8 mg Folic Acid 0.3-0.8 mg
- - -
- Biotina 0,02-0,4 mg Biotin 0.02-0.4 mg
- - -
- Yodo 0,1-0,5 mg Iodine 0.1-0.5 mg
- - -
- Zinc 11-13 mg Zinc 11-13 mg
- - -
- Lactobacillus Rhamnosus 5x1010 UFC Lactobacillus Rhamnosus 5x1010 CFU
- - -
- Lactobacillus Reuteri 5x1010 UFC Lactobacillus Reuteri 5x1010 UFC
Para esta capsula en particular la dosis recomendada es de una unidad al dia.For this particular capsule the recommended dose is one unit per day.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201531147A ES2551053B1 (en) | 2015-07-31 | 2015-07-31 | Polyvitamin food supplement for pregnant women |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201531147A ES2551053B1 (en) | 2015-07-31 | 2015-07-31 | Polyvitamin food supplement for pregnant women |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2551053A1 ES2551053A1 (en) | 2015-11-13 |
| ES2551053B1 true ES2551053B1 (en) | 2016-09-06 |
Family
ID=54398557
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES201531147A Active ES2551053B1 (en) | 2015-07-31 | 2015-07-31 | Polyvitamin food supplement for pregnant women |
Country Status (1)
| Country | Link |
|---|---|
| ES (1) | ES2551053B1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107373487A (en) * | 2017-07-20 | 2017-11-24 | 赵成群 | A kind of ferrous bisglycinate chelate electuary |
| WO2023209224A1 (en) * | 2022-04-29 | 2023-11-02 | Université Libre de Bruxelles | Probiotics for the prevention or treatment of viral respiratory infections |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4905300A (en) * | 1999-05-25 | 2000-12-12 | Andrew W. Bruce | Oral administration of lactobacillus for the maintenance of health in women |
| EP2011506A1 (en) * | 2007-07-05 | 2009-01-07 | Nestec S.A. | Supplementation of maternal diet |
| EP2609814A1 (en) * | 2011-12-30 | 2013-07-03 | Nestec S.A. | Lactobacillus reuteri DSM 17938 for the development of cognitive function |
| US9241923B2 (en) * | 2013-07-16 | 2016-01-26 | Mead Johnson Nutrition Company | Methods for promoting neuronal development and/or health |
-
2015
- 2015-07-31 ES ES201531147A patent/ES2551053B1/en active Active
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107373487A (en) * | 2017-07-20 | 2017-11-24 | 赵成群 | A kind of ferrous bisglycinate chelate electuary |
| WO2023209224A1 (en) * | 2022-04-29 | 2023-11-02 | Université Libre de Bruxelles | Probiotics for the prevention or treatment of viral respiratory infections |
Also Published As
| Publication number | Publication date |
|---|---|
| ES2551053A1 (en) | 2015-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6569857B1 (en) | Dietary supplement | |
| ES2275514T3 (en) | COMPLEMENTARY NUTRITIONAL CONTRIBUTIONS. | |
| US7112609B2 (en) | Nutritional supplements | |
| ES2423682T3 (en) | Supplement for mothers | |
| AU2005251687A1 (en) | Nutritional formulations | |
| KR20080009075A (en) | Nutritional preparations | |
| ES2620057T3 (en) | Composition of infant food comprising viable bacteria producing propionic acid and viable bacteria producing lactic acid | |
| ES2569238T3 (en) | Procedures and compositions for treating thyroid-related medical conditions with reduced folates | |
| CN108477622A (en) | A kind of infant's global function alimentation composition | |
| ES2551053B1 (en) | Polyvitamin food supplement for pregnant women | |
| US20190167766A1 (en) | Formulations for Nutritional Support in Subjects in Need Thereof | |
| ES2755949T3 (en) | Myoinositol and probiotics and their use to prevent excess weight in young infants | |
| US20230027781A1 (en) | Prenatal Dosage Forms, Methods of Administration and Kits Thereof | |
| RU2013150838A (en) | LACTOBACILLUS PARACASEI NCC2461 (ST11) FOR PERINATAL PERIOD USE IN WOMEN TO REDUCE AND PREVENT ALLERGIC PHENOMENA IN CHILDREN | |
| CN101176734A (en) | Nutrients replenisher for replenishing folic acid and vitamin B12 and preparation method thereof | |
| CN104413527B (en) | Composite functional beverage composition | |
| CN101269210A (en) | Ketogenic mix preparation suitable for treating intractable epilepsy | |
| CN105106217A (en) | Nutritional supplement for pregnant women and preparation method thereof | |
| TR201808808T4 (en) | Composition for the treatment of hypocalcemia in ruminants. | |
| US20150104539A1 (en) | Citrated folic acid compositions and methods for delivering folic acid to usp dissolution specifications | |
| GB2459657A (en) | Postnatal dietary supplement. | |
| ES2550521B1 (en) | Food supplement for female fertility | |
| CN107889889A (en) | A kind of formula for the Astaxanthin In Haematococcus Pluvialis milk powder for contributing to recovery of parturient | |
| ES2550522B1 (en) | Food supplement for male fertility | |
| CN111165811A (en) | Composition for rapidly providing energy required by delivery of lying-in women |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 2551053 Country of ref document: ES Kind code of ref document: B1 Effective date: 20160906 |